Benefits
Cholesterol Reduction
Bundy 2008 RCT showed artichoke leaf extract (1,280 mg/day) significantly reduced total cholesterol vs placebo over 12 weeks in adults with mild-moderate hypercholesterolemia. Multiple subsequent trials and meta-analyses (Sahebkar 2018) confirm modest cholesterol-lowering effects — typically 5-15% reduction.
Functional Dyspepsia / Indigestion
Strong evidence for relief of dyspeptic complaints (bloating, fullness, nausea, abdominal pain). Holtmann 2003 trial showed significant improvement vs placebo. Approved indication in European herbal medicine (German Commission E).
IBS Symptom Relief
Bundy 2004 trial showed artichoke significantly reduced IBS symptoms and improved quality of life in 208 IBS patients. Particularly effective for IBS with constipation predominance via bile flow stimulation.
Choleretic / Bile Flow Stimulation
Increases bile production and flow — foundational mechanism. Useful for fat digestion, gallbladder support (in absence of gallstones), and supporting fat-soluble nutrient absorption.
Hepatoprotection
Animal models show protection against drug-induced and alcohol-induced hepatotoxicity. Modest reductions in liver enzymes (ALT, AST) in some trials. Mechanism: glutathione support, antioxidant activity, bile flow stimulation.
Mechanism of action
Cynarin Choleretic Activity
Cynarin (1,5-dicaffeoylquinic acid) is the primary active — stimulates bile production by hepatocytes and bile flow through bile ducts. Increased bile flow improves fat digestion and provides excretory route for cholesterol and toxins.
HMG-CoA Reductase Modulation
Artichoke compounds modestly inhibit HMG-CoA reductase (the same enzyme statins block) — basis for cholesterol-lowering effects. Effect substantially weaker than statins.
Antioxidant Activity (Polyphenols)
Chlorogenic acid, luteolin, and other polyphenols provide direct antioxidant activity plus support of endogenous antioxidant systems. Concentrated in leaves rather than the edible bud.
GI Motility / Carminative Effects
Bitter compounds stimulate digestive secretions; antispasmodic effects on smooth muscle reduce bloating and cramping. Traditional bitter herb mechanism.
Clinical trials
RCT of artichoke leaf extract (1,280 mg/day) vs placebo in 75 adults with mild-moderate hypercholesterolemia for 12 weeks.
75 adults with hypercholesterolemia.
Significant reduction in total cholesterol vs placebo. Modest but clinically meaningful. Established artichoke as evidence-based natural cholesterol support.
Open-label observational trial of artichoke leaf extract in 208 IBS patients for 8 weeks.
208 IBS patients.
26% reduction in IBS symptom severity, significant quality of life improvement. Particularly effective for constipation-predominant IBS. Generated subsequent RCT support.
About this ingredient
Artichoke (Cynara scolymus, sometimes classified as Cynara cardunculus var. scolymus) is a CULTIVATED THISTLE native to the MEDITERRANEAN — the edible 'globe artichoke' is the immature flower bud, but the MEDICINAL PART IS THE LEAVES (cynarin and other compounds are far more concentrated in leaves than buds). Used since Roman and Greek times for liver and digestive complaints.
KEY ACTIVES: (1) CYNARIN (1,5-dicaffeoylquinic acid) — primary choleretic; (2) CHLOROGENIC ACID — major polyphenol; (3) LUTEOLIN and other flavonoids; (4) SESQUITERPENE LACTONES (cynaropicrin) — bitter compounds; (5) INULIN (in tubers/roots) — soluble fiber. PRODUCT FORMS: standardized leaf extracts (typical standardization 2-5% caffeoylquinic acids OR 13-18% chlorogenic acid).
EVIDENCE-BASED USES: (1) HYPERCHOLESTEROLEMIA — Bundy 2008, multiple meta-analyses; modest effects; (2) FUNCTIONAL DYSPEPSIA — German Commission E approved; Holtmann 2003; (3) IBS, especially constipation-predominant — Bundy 2004; (4) Choleretic / bile flow stimulation; (5) Hepatoprotection (modest).
CRITICAL CAUTIONS: (1) GALLSTONES / BILE DUCT OBSTRUCTION — increased bile flow can DISLODGE gallstones into bile ducts causing biliary colic; AVOID without medical supervision in those with known gallstones or biliary obstruction; consult gastroenterologist; (2) ASTERACEAE ALLERGIES — cross-reactive with ragweed, daisy, chrysanthemum, marigold, chamomile family; AVOID if known Asteraceae allergy; (3) PREGNANCY/LACTATION — culinary use safe; concentrated extracts limited safety data; AVOID supplementation; (4) DOSE — 320-1,800 mg/day standardized extract; clinical trials use 600-1,920 mg/day; (5) STATIN COMBINATION — additive cholesterol effects; not contraindicated but monitor; (6) BITTER PRINCIPLE — sesquiterpene lactones may cause unpalatability; many products use coated tablets; (7) FOOD VS SUPPLEMENT — eating artichoke buds (the culinary part) provides modest fiber/nutrition but minimal cynarin (which is in leaves); for therapeutic effects, leaf extract is the form to use; (8) JERUSALEM ARTICHOKE — completely different plant (Helianthus tuberosus); not interchangeable; (9) The strong evidence base distinguishes artichoke from many less-studied herbs — German Commission E and ESCOP approval reflect substantive clinical research; (10) IRON ABSORPTION — chlorogenic acid binds iron; relevant for iron-deficient patients; separate iron supplements by 2 hours; (11) DIETARY ARTICHOKE provides inulin (prebiotic fiber) — beneficial for gut microbiome; supplemental leaf extract is for therapeutic indications; (12) 'CYNARA' BRAND extracts (e.g., Cynara-SL, Hepar-SL) are the most clinically-studied formulations.